234 related articles for article (PubMed ID: 10558949)
1. Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera.
Villaseñor-Sierra A; McShan WM; Salmi D; Kaplan EL; Johnson DR; Stevens DL
J Infect Dis; 1999 Dec; 180(6):1921-8. PubMed ID: 10558949
[TBL] [Abstract][Full Text] [Related]
2. Type-specific opsonophagocytosis of group A Streptococcus by use of a rapid chemiluminescence assay.
Villaseñor-S A; Bryant AE; Stevens DL
J Infect Dis; 1999 May; 179(5):1293-6. PubMed ID: 10191240
[TBL] [Abstract][Full Text] [Related]
3. Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non-opsonic epitopes.
Sandin C; Carlsson F; Lindahl G
Mol Microbiol; 2006 Jan; 59(1):20-30. PubMed ID: 16359315
[TBL] [Abstract][Full Text] [Related]
4. Streptococcal defenses against host immune attack: the M protein-fibrinogen interaction.
Whitnack E; Dale JB; Beachey EH
Trans Assoc Am Physicians; 1983; 96():197-202. PubMed ID: 6208666
[No Abstract] [Full Text] [Related]
5. Variation in M protein production among Streptococcus pyogenes strains according to emm genotype.
Matsumoto M; Suzuki M; Hirose K; Hiramatsu R; Minagawa H; Minami M; Tatsuno I; Okamoto A; Ohta M; Hasegawa T
Microbiol Immunol; 2011 Jun; 55(6):379-87. PubMed ID: 21371090
[TBL] [Abstract][Full Text] [Related]
6. Recombinant tetravalent group A streptococcal M protein vaccine.
Dale JB; Chiang EY; Lederer JW
J Immunol; 1993 Aug; 151(4):2188-94. PubMed ID: 8345202
[TBL] [Abstract][Full Text] [Related]
7. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.
Yoonim N; Olive C; Pruksachatkunakorn C; Pruksakorn S
BMC Microbiol; 2006 Aug; 6():71. PubMed ID: 16895610
[TBL] [Abstract][Full Text] [Related]
8. The role of M protein in phagocytosis. II. Opsonization of Streptococcus pyogenes in vitro.
Tylewska S; Hryniewicz W
Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):44-7. PubMed ID: 44622
[TBL] [Abstract][Full Text] [Related]
9. Domains of group A streptococcal M protein that confer resistance to phagocytosis, opsonization and protection: implications for vaccine development.
McArthur JD; Walker MJ
Mol Microbiol; 2006 Jan; 59(1):1-4. PubMed ID: 16359313
[TBL] [Abstract][Full Text] [Related]
10. Streptococcus pyogenes strains containing emm12 and emm55 possess a novel gene coding for distantly related SIC protein.
Hartas J; Sriprakash KS
Microb Pathog; 1999 Jan; 26(1):25-33. PubMed ID: 9973578
[TBL] [Abstract][Full Text] [Related]
11. Mapping a conserved conformational epitope from the M protein of group A streptococci.
Relf WA; Cooper J; Brandt ER; Hayman WA; Anders RF; Pruksakorn S; Currie B; Saul A; Good MF
Pept Res; 1996; 9(1):12-20. PubMed ID: 8727479
[TBL] [Abstract][Full Text] [Related]
12. M protein conserved region antibodies opsonise multiple strains of Streptococcus pyogenes with sequence variations in C-repeats.
Vohra H; Dey N; Gupta S; Sharma AK; Kumar R; McMillan D; Good MF
Res Microbiol; 2005 May; 156(4):575-82. PubMed ID: 15862457
[TBL] [Abstract][Full Text] [Related]
13. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
Lagergård T; Frisk A; Purvèn M; Nilsson LA
Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
[TBL] [Abstract][Full Text] [Related]
14. Sequence and type-specific immunogenicity of the amino-terminal region of type 1 streptococcal M protein.
Kraus W; Haanes-Fritz E; Cleary PP; Seyer JM; Dale JB; Beachey EH
J Immunol; 1987 Nov; 139(9):3084-90. PubMed ID: 2444650
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic variability of X-protein expression by mastitis-causing Streptococcus agalactiae of serotype NT/X and opsonic activities of specific antibodies.
Rainard P; Sarradin P; Poutrel B
Microb Pathog; 1994 May; 16(5):359-72. PubMed ID: 7815919
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci.
Dale JB; Washburn RG; Marques MB; Wessels MR
Infect Immun; 1996 May; 64(5):1495-501. PubMed ID: 8613352
[TBL] [Abstract][Full Text] [Related]
17. Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemics.
Hoe NP; Kordari P; Cole R; Liu M; Palzkill T; Huang W; McLellan D; Adams GJ; Hu M; Vuopio-Varkila J; Cate TR; Pichichero ME; Edwards KM; Eskola J; Low DE; Musser JM
J Infect Dis; 2000 Nov; 182(5):1425-36. PubMed ID: 11015234
[TBL] [Abstract][Full Text] [Related]
18. Expression of two different antiphagocytic M proteins by Streptococcus pyogenes of the OF+ lineage.
Thern A; Wästfelt M; Lindahl G
J Immunol; 1998 Jan; 160(2):860-9. PubMed ID: 9551922
[TBL] [Abstract][Full Text] [Related]
19. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.
Brandt ER; Sriprakash KS; Hobb RI; Hayman WA; Zeng W; Batzloff MR; Jackson DC; Good MF
Nat Med; 2000 Apr; 6(4):455-9. PubMed ID: 10742155
[TBL] [Abstract][Full Text] [Related]
20. Membrane cofactor protein (MCP, CD46) binding to clinical isolates of Streptococcus pyogenes: binding to M type 18 strains is independent of Emm or Enn proteins.
Feito MJ; Sánchez A; Oliver MA; Pérez-Caballero D; Rodríguez de Córdoba S; Albertí S; Rojo JM
Mol Immunol; 2007 Jul; 44(14):3571-9. PubMed ID: 17467801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]